Abstract
In human B lymphocytes latently infected in vitro and in vivo with Epstein-Barr virus (EBV), including Burkitt’s lymphoma (BL) cells and various other EBV-related tumor cells, the viral DNA persists mostly in a circular episomal form with multiple copies and expresses a limited number of viral genes, while some of the latent EBV DNA may be integrated into the host chromosomal DNA (Kieff 1996; Hirai et al. 1998 for review). The original definition of the term “episome” coined by Jacob and Wollman (1961) is a genetic factor that can persist in both the integrated state and as an extrachromosomal replicon in host cells. However, the term episome has also been used to describe the circular, extrachromosomal plasmid state of the latent EBV genome in most recent papers related to the state of latent EBV. We also follow this definition.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Adams A (1987) Replication of latent Epstein-Barr virus genomes in Raji cells. J Virol 61:1743–1746
Aiyar A, Tyree C, Sugden B (1998) The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element. EMBO J 17:6394–6403
Ambinder RF, Mullen MA, Chang YN, Hayward GS, Hayward SD (1991) Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. J Virol 65:1466–1478
Avolio-Hunter TM, Frappier L (1998) Mechanistic studies on the DNA linking activity of Epstein-Barr nuclear antigen 1. Nucleic Acids Res 26:4462–4470
Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA (1998) EBV persistence in memory B cell in vivo. Immunity 9:395–404
Bell SP, Stillman B (1992) Nucleotide dependent recognition of chromosomal origins of DNA replication by a multi-protein complex. Nature 357:128–134
Blow JJ, Laskey RA (1988) A role for the nuclear envelope in controlling DNA replication within the cell cycle. Nature 332:546–548
Bochkarev A, Barwell JA, Pfuetzner RA, Furey WJr, Edwards AM, Frappier L (1995) Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein EBNA1. Cell 83:39–46
Bochkarev A, Barwell JA, Pfuetzner RA, Bochkareva E, Frappier L, Edwards AM (1996) Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein, EBNA1, bound to DNA. Cell 84:791–800
Bousset K, Diffley JF (1998) The Cdc7 protein kinase is required for origin firing during S phase. Genes Dev 12:480–490
Brewer BJ, Fangman WL (1987) The localization of replication origins on ARS plasmids in S. cerevisiae. Cell 51:463–471
Chatterjee A, Freeman JW, Busch H (1987) Identification and partial characterization of a Mr 40,000 nucleolar antigen associated with cell proliferation. Cancer Res 47:1123–1129
Chen MR, Middeldorp JM, Hayward SD (1993) Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure. J Virol 67:4875–4885
Chen F, Zou JZ, di Renzo L, Winberg G, Hu LF, Klein E, Klein G, Ernberg I (1995) A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J Virol 69:3752–3758
Chong JPJ, Mahbubani HM, Khoo CY, Blow JJ (1995) Purification of an MCM-containing complex as a component of the DNA replication licensing system. Nature 375:418–421
Cook PR (1999) The organization of replication and transcription. Science 284:1790–1795
Decker LL, Klaman LD, Thorley-Lawson DA (1996) Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individulas. J Virol 70:3286–3289
Delecluse EH, Bartnike S, Hammerschmidt W, Bullerdiek J, Bornkamm GW (1993) Episomal and integrated copies of Epstein-Barr virus coexist in Burkitt lymphoma cell lines. J Virol 67:1292–1299
DePamphilis ML (1995) Specific labeling of newly replicated DNA. Methods in Enzymology 262:628–669
Deshpande AM, Newlon CS (1996) DNA replication fork pause sites dependent on transcription. Science 272:1030–1033
Diffley JF, Cocker JH, Dowell SJ, Rowley A (1994) Two steps in the assembly of complexes at yeast replication origins in vivo. Cell 78:303–316
Donaldson AD, FangmanWL, Brewer BJ (1998) Cdc7 is required throughout the yeast S phase to activate replication origins. Genes Dev 12:491–501
Frappier L, O’Donnell M (1991a) Overproduction, purification, and characterization of EBNA-1, the origin binding protein of Epstein-Barr virus. J Biol Chem 266:7819–7826
Frappier L, O’Donnell M (1991b) Epstein-Barr nuclear antigen-1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus. Proc Natl Acad Sci USA 88:10875–10879
Frappier L, O’Donnell M (1992) EBNA1 distorts oriP, the Epstein-Barr virus latent replication origin. J Virol 66:1786–1790
Gahn TA, Schildkraut CL (1989) The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication. Cell 58:527–535
Goldsmith K, Bendell L, Frappier L (1993) Identification of EBNA1 amino acid sequences required for the interaction of the functional elements of the Epstein-Barr virus latent origin of DNA replication. J Virol 67:3418–3426
Grogan EA, Summers WP, Dowling S, Shedd D, Gradoville L, Miller G (1983) Two Epstein-Barr viral nuclear neoantigens distinguished by gene transfer, serology, and chromosome binding. Proc Natl Acad Sci USA 80:7650–7653
Gualandi G, Santolini E, Calef E (1992) Epstein-Barr virus DNA recombines via latent origin of replication with the human genome in the lymphoblastoid cell line RGN1. J Virol 66:5677–5681
Gulley ML, Raphael M, Lutz CT, Ross DW, Raab-Traub N (1992) Epstein-Barr virus integration in human lymphomas and lymphoid cell lines. Cancer 70:185–191
Haase SB, Heinzel SS, Calos MP (1994) Transcription inhibits the replication of autonomously replicating plasmids in human cells. Mol Cell Biol 14:2516–2524
Hammerschmidt W, Sugden B (1988) Identification and characterization of orilyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell 55:427–433
Hamper B, Tanaka A, Nonoyama M, Derge JG (1974) Replication of the resident repressed Epstein-Barr virus genome during the early S-phase (S-1 period) of nonproducer Raji cells. Proc Natl Acad Sci USA 71:631–635
Harris A, Young BD, Griffin BE (1985) Random association of Epstein-Barr virus genomes with host cell metapahase chromosomes in Burkitt’s lymphoma-derived cell lines. J Virol 56:328–332
Harrison S, Fisenne K, Hearing J (1994) Sequence requirements of the Epstein-Barr virus latent origin of DNA replication. J Virol 68:1913–1925
Hasseil JA, Briton BT (1996) SV40 and Polyomavirus DNA replication. In: DePamphilis ML (ed) DNA replication in eukaryotic cells. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
Heller M, Henderson A, Kieff E (1982) Repeat array in Epstein-Barr virus DNA is related to cell DNA sequences interspersed on human chromosomes. Proc Natl Acad Sci USA 79:5916–5920
Henderson A, Ripley S, Heller M, Kieff E (1983) Chromosome site for Epstein-Barr virus in a Burkitt tumor cell line and in lymphocytes growth-transformed in vitro. Proc Natl Acad Sci USA 80:1987–1991
Hennessy K, Heller M, van Santan V, Kieff E (1983) simple repeat array in Epstein-Barr virus DNA encodes part of the Epstein-Barr nuclear antigen. Science 220:1396–1398
Hirai K, Hironaka T, Yamamoto T (1993) Structure and expression of standard Epstein-Barr virus DNA in a P3HR-1 subclone containing a single viral genome equivalent per cell. In: Tursz T, Pagano JS, Albashi DV, de The G, Lenoir G, Pearson GR (eds) The Epstein-Barr virus and associated diseases. Colloque INSERM/John Libbey Eurotext Ltd, Vol 225, pp 289–294
Hirai K, Yamamoto T, Hironaka T, Arai T, Takeuchi H, Kobayashi R, Hojo I, Oishi T (1998) Epstein-Barr virus genome in infected cells and cancer. In: Osato T, Takada K, Tokunaga M (eds) Epstein-Barr virus and human cancer. Monograph on cancer research No.45, Japan Scientific Societies Press Karger,pp 29–39
Hsieh DJ, Camiolo SM, Yates J (1993) Constitutive binding of EBNA1 protein to the Epstein-Barr virus replication origin, oriP, with distortion of DNA structure during latent infection. EMBO J 12:4933–4944
Hurley E, Klaman LD, Agger S, Lawrence JB, Thorley-Lawson DA (1991) The prototypical Epstein-Barr virus-transformed lymphoblastoid cell line IB4 is an unusual variant containing integrated but no episomal viral DNA. J Virol 65:3958–5963
Ikeda T, Kobayashi R, Horiuchi M, Nagata Y, Hasegawa M, Mizuno F, Hirai K (2000) Detection of lymphocytes productively infected with Epstein-Barr Virus in non-neoplastic tonsils. J Gen Virol in press
Jacob F, Wollman E (1961) Sexuality and the genetics of bacteria. Academic Press
Jankelevich S, Kolman JL, Bodnar JW, Miller G (1992) A nuclear matrix attachment region organizes the Epstein-Barr viral plasmid in Raji cells into a single DNA domain. EMBO J 11:1165–1176
Kirchmaier AL, Sugden B (1998) Rep*: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus. J Virol 72:4657–4666
Klipalani-Joshi S, Law HY (1994) Identification of integrated Epstein-Barr virus in nasopharyngeal carcinoma using pulse field gel electrophoresis. Int J Cancer 56:187–192
Kobayashi R, Takeuchi H, Sasaki M, Hasegawa M, Hirai K (1998) Detection of Epstein-Barr Virus infection in the epithelial cells and lymphocytes of non-neoplastic tonsils by in situ hybridization and in situ PCR. Arch Virol 143:803–813
Krysan PJ, Haase SB, Calos MP (1989) Isolation of human sequences that replicate autonomously in human cells. Mol Cell Biol 9:1026–1033
Kubota Y, Mimura S, Nishimoto SI, Takisawa H, Nojima H (1995) Identification of the yeast MCM3-related protein as a component of Xenopus DNA replication licensing factor. Cell 81:601–609
Kumagai H, Sato N, Yamada M, Mahony D, Seghezzi W, Lees E, Arai K, Masai H (1999) A novel growth- and cell cycle-regulated protein, ASK, activates human Cdc7-related kinase and is essential for Gl/S transition in mammalian cells. Mol Cell Biol 19:5083–5095
Laine A, Frappier L (1995) Identification of Epstein-Barr nuclear antigen 1 protein domains that direct interactions at a distance between DNA-bound proteins J Biol Chem 270:30914–30918
Lawrence JB, Villnave CA, Singer RH (1988) Sensitive, high-resolution chromatin and chromosome mapping in situ: presence and orientation of two closely integrated copies of EBV in a lymphoma line. Cell 52:51–61
Lee MA, Diamond ME, Yates JL (1999) Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus. J Virol 73:2974–2982
Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, Kurilla MG, Masucci MG (1995) Inhibition of antigen processing by the repeat region of the Epstein-Barr nuclear antigen 1. Nature 375:685–688
Little R, Schildkraut C (1995) Initiation of latent DNA replication in the Epstein-Barr virus genome can occur at sites other than the genetically defined origin. Mol Biol Cell 5:2893–2903
Lupton S, Levine AJ (1985) Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus derived plasmids in human cells. Mol Cel Biol 5: 2533–2542
Mackey D, Middleton T, Sugden B (1995) Multiple regions within EBNA1 can link DNAs. J Virol 69:6199–6208
Madine MA, Khoo CY, Milles AD, Laskey RA (1995) MCM3 complex required for cell cycle regulation of DNA replication in vertebrate cells. Nature 375:421–424
Marechal V, Dehee A, Chikhi-Brachet R, Piolot T, Coppey-Moisan M, Nicolas JC (1999) Mapping EBNA-1 domains involved in binding to metaphase chromosomes. J Virol 73:4385–4392
Matsuo T, Heller M, Petti L, Oshiro E, Kieff E (1984) Persistence of the entire EBV genome integrated into human lymphocyte DNA. Science 226:1322–1325
Middleton T, Sugden B (1992) EBNA1 can link the enhancer element to the initiator element of the Epstein-Barr virus plasmid origin of DNA replication. J Virol 66:489–495
Middleton T, Sugden B (1994) Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein. J Virol 68:4067–4071
Miyashita EM, Yang B, Lam KMC, Crawford DC, Thorley-Lawson DA (1995) A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 80:593–601
Newlon CS (1997) Putting it all together: building a rereplicative complex. Cell 91:717–720
Niller HH, Glaser G, Knuchel R, Wolf H (1995) Nucleoprotein complexes and DNA 5’-ends at oriP of Epstein-Barr virus. J Biol Chem 270:12864–12868
Petti L, Sample C, Kieff E (1990) Subnucler localization and phosphorylation or Epstein-Barr virus latent infection nuclear proteins. Virology 176:563–574
Polvino-Bodnar M, Schaffer PA (1992) Mutational analysis of Epstein-Barr virus nuclear antigen (EBNA-1). Nucleic Acids Res 16:3415–3435
Qu L, Rowe DT (1992) Epstein-Barr virus latent gene expression in cultured peripheral blood lymphocytes. J Virol 66:3715–3724
Rawlins DR, Milman G, Hayward SD, Hayward GS (1985) Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region Cell 42:859–868
Reedman BM, Klein G (1973) Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer 11:499–520
Reisman D, Yates J, Sugden B (1985) A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol Biol Cell 5:1822–1832
Roberts BT, Ying CY, Gautier J, Maller JL (1999) DNA replication in vertebrates requires a homolog of the Cdc7 protein kinase. Proc Natl Acad Sci USA 96:2800–2804
Santocanale C, Diffley JF (1996) ORC- and Cdc6-dependent complexes at active and inactive chromosomal replication origins in Saccharomyces cerevisiae. EMBO J 15:6671–6679
Shiraishi Y, Taguchi T, Ohta Y, Hirai K (1985) Chromosomal localization of the Epstein-Barr virus (EBV) genome in Bloom’s syndrome B-lymphoblastoid cell lines transformed with EBV. Chromo-soma 93:157–164
Shirakata M, Hirai K (1998) Identification of minimal oriP of Epstein-Barr virus required for DNA replication. J Biochem 123:175–181
Shirakata M, Imadome K, Hirai K (1999) Requirement of replication licensing for the dyad symmetry element-dependent replication of the EBV oriP minichromosome. Virology 263:42–54
Shire K, Ceccarelli DFJ, Avolio-Hunter TM, Frappier L (1999) EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance. J Virol 73:2587–2595
Simpson K, McGuigan A, Huxley C (1996) Stable episome maintenance of yeast chromosomes in human cells. Mol Cell Biol 16:5117–5126
Snudden DE, Hearing J, Smith PR, Grasser FA, Griffin BE (1994) EBNA1, the major nuclear antigen of Epstein-Barr virus, resembles RGG’ RNA binding proteins. EMBO J 13:4840–4847
Solomon MJ, Larsen PL, Varshavsky A (1988) Mapping protein-DNA interactions in vivo with formaldehyde: evidence that histone H4 is retained on a highly transcribed gene. Cell 53:937–947
Stenlund A (1996) Papillomavirus DNA replication. In: DePamphilis ML (ed) DNA replication in eukaryotic cells. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
Strahl-Bolsinger S, Hecht A, Luo K, Grunstein M (1997) SIR2 and SIR4 interactions differ in core and extended telomeric heterochromatin in yeast. Gene Dev 11:83–93
Su W, Middleton T, Sugden B, Echols H (1991) DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: Stabilization of an origin complex with Epstein-Barr nuclear antigen 1. Proc Natl Acad Sci USA 88:10870–10874
Takeda T, Ogino K, Matsui E, Cho MK, Kumagai H, Miyake T, Arai K, Masai H (1999) A fission yeast gene, himl( + )/dfpl( + ), encoding a regulatory subunit for Hsk l kinase, plays essential roles in S-phase initiation as well as in S-phase checkpoint control and recovery from DNA damage. Mol Cell Biol 19:5535–5547
Thömmes P, Kubota Y, Takisawa H, Blow JJ (1997) The RLF-M component of the replication licensing system forms complexes containing all six MCM/Pl Polypeptides. EMBO J 16:3312–3319
Thorley-Lawson DA, Miyashita EM, Kahn G (1996) Epstein-Barr virus and the B cell: that all it takes. Trends Microbiol 4:204–208
Tierney RJ, Steven N, Young LS, Rickinson AB (1994) Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state. J Virol 68:7374–7385
Wendelburg BJ, Vos JM (1998) An enhanced EBNA1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells. Gene Ther 5:1389–1399
Wysokenski DA, Yates J (1989) Multiple EBNA-1-binding sites are required to form an EBNA1- dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. J Virol 63:2657–2666
Yandava CN, Speck SH (1992) Characterization of the deletion and rearrangement in the BamHI C region of the X50-7 Epstein-Barr virus genome, a mutant viral strain which exhibits constitutive BamHI W promoter activity. J Virol 66:5646–5650
Yates JL, Warren N, Reisman D, Sugden B (1984) A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci USA 81:3806–3810
Yates JL, Wallen N, Sugden B (1985) Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313:812–815
Yates JL, Guan N (1991) Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells. J Virol 65:483–488
Yates JL (1996) Epstein-Barr virus DNA replication. In: DePamphilis ML (ed) DNA replication in eukaryotic cells. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
Zhang D, Frappier L, Gibbs E, Hurwitz J, O’Donnell M (1998) Human RPA (hSSB) interacts with EBNA1, the latent origin binding protein of Epstein-Barr virus. Nuc Acids Res 26:631–637
Zou L, Stillman B (1998) Formation of a preinitiation complex by S-phase cyclin-dependent loading of Cdc45p onto chromatin. Science 280:593–596
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hirai, K., Shirakata, M. (2001). Replication Licensing of the EBV oriP Minichromosome. In: Takada, K. (eds) Epstein-Barr Virus and Human Cancer. Current Topics in Microbiology and Immunology, vol 258. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56515-1_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-56515-1_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62568-8
Online ISBN: 978-3-642-56515-1
eBook Packages: Springer Book Archive